Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Licenses Kreatech's ULS Labeling Tech for Use With aCGH Platform

NEW YORK (GenomeWeb News) — Agilent Technologies has licensed labeling technology from Kreatech for use with its formalin-fixed paraffin-embedded DNA tissue-extraction method, Agilent said today.
 
Agilent said it will use Kreatech’s Universal Linkage System, which is a non-enzymatic direct-labeling methodology that has been optimized to be used with Agilent’s oligo comparative genomic hybridization microarrays.
 
There are around 400 million FFPE-preserved DNA samples in tissue banks that are “too degraded to use in microarray analysis techniques such as aCGH,” the company said. 
 
Having the capability to access degraded FFPE samples for microarray use offers “tremendous promise for cancer researchers,” Jay Kaufman, Agilent’s marketing director, said in a statement.
 
Financial terms of the agreement were not released.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.